𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Regulation of P-glycoprotein by human immunodeficiency virus-1 in primary cultures of human fetal astrocytes

✍ Scribed by Tamima Ashraf; Patrick T. Ronaldson; Yuri Persidsky; Reina Bendayan


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
760 KB
Volume
89
Category
Article
ISSN
0360-4012

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

P‐glycoprotein (P‐gp), a drug efflux pump, is known to alter the bioavailability of antiretroviral drugs at several sites, including the brain. We have previously shown that human immunodeficiency virus‐1 (HIV‐1) glycoprotein 120 (gp120) induces proinflammatory cytokine secretion and decreases P‐gp functional expression in rat astrocytes, a cellular reservoir of HIV‐1. However, whether P‐gp is regulated in a similar way in human astrocytes is unknown. This study investigates the regulation of P‐gp in an in vitro model of gp120‐triggered human fetal astrocytes (HFAs). In this system, elevated levels of interleukin‐6 (IL‐6), IL‐1β, and tumor necrosis factor‐α were detected in culture supernatants. Pretreatment with CCR5 neutralizing antibody attenuated cytokine secretion, suggesting that gp120‐CCR5 interaction mediated cytokine production. Treatment with gp120 (R5‐tropic) resulted in reduced P‐gp expression (64%) and function as determined by increased (1.6‐fold) cellular accumulation of [^3^H]digoxin, a P‐gp substrate. Exposure to R5 or R5/X4‐tropic viral isolates led to a downregulation in P‐gp expression (75% or 90%, respectively), and treatment with IL‐6 also showed lower P‐gp expression (50%). Moreover, IL‐6 neutralizing antibody blocked gp120‐mediated P‐gp downregulation, suggesting that IL‐6 is a key modulator of P‐gp. Gp120‐ or IL‐6‐mediated downregulation of P‐gp was attenuated by SN50 (a nuclear factor‐κB [NF‐κB] inhibitor), suggesting involvement of NF‐κB signaling in P‐gp regulation. Our results suggest that, similarly to the case with rodent astrocytes, pathophysiological stressors associated with brain HIV‐1 infection have a downregulatory effect on P‐gp functional expression in human astrocytes, which may ultimately result in altered antiretroviral drug accumulation within brain parenchyma. © 2011 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Expression and regulation of cytochrome
✍ Edward L. LeCluyse; Ajay Madan; Geraldine Hamilton; Kathy Carroll; Ryan DeHaan; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB 👁 1 views

The aim of this study was to test suitable culture conditions for maintaining normal cellular cytoarchitecture and inducibility of P450 enzymes in primary cultures of human hepatocytes by prototypical inducers. The selectivity and sensitivity of a sandwich culture system were determined by treating

Regulation of cytochrome P450 2C9 expres
✍ Jasminder Sahi; Stacy S. Shord; Celeste Lindley; Stephen Ferguson; Edward L. LeC 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB 👁 1 views

Cytochrome P450 2C9 (CYP2C9) expression is regulated by multiple nuclear receptors including the constitutive androstane receptor (CAR) and pregnane X receptor (PXR). We compared coregulation of CYP2C9 with CYP2B6 and CYP3A4, prototypical target genes for human CAR and PXR using human hepatocyte cul

Functional expression of p-glycoprotein
✍ X. Declèves; A. Regina; J.-L. Laplanche; F. Roux; B. Boval; J.-M. Launay; J.-M. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 2 views

Although it has been well established that the drug efflux pump P-glycoprotein (P-gp) protects the brain against the entry of cytotoxic drugs, its real in situ localization, i.e., at brain capillary endothelial cells or on astrocyte foot processes, is still controversial. The aim of this study was t

Induction of Epstein-Barr virus in B-lym
✍ Patrick K. Lai; Xu Li; David J. Volsky 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 861 KB

Individuals infected with the human immunodeficiency virus (HIV), the etiologic agent of acquired immunodeficiency syndrome (AIDS), often show symptoms associated with reactivation of Epstein-Barr virus (EBV). In this study, we show that exposure of EBV-positive B lymphocytes to HIV-I in vitro induc